Cross platform analysis of drug targets and toxicity of bath salts
Project Number3U01DA054330-03S1
Former Number5U01DA054330-02
Contact PI/Project LeaderSCHIEFER, ISAAC T
Awardee OrganizationUNIVERSITY OF TOLEDO HEALTH SCI CAMPUS
Description
Abstract Text
PROJECT SUMMARY/ABSTRACT
The parent award is focused on studying the mechanisms of novel psychoactive agents, with an emphasis on
phenethylamines. Some of these agents are hallucinogenic and induce pronounced long term changes in
dendritic branching and synaptic plasticity (termed as psychoplastogens). Even acute treatments with
dimethyltryptamine (DMT), an agent from a related class (an indole-alkylamine) results in long term synaptic
rewiring. The mechanisms behind these effects are the focus of significant interest for neuropsychiatric disorders
and may have applications for dementia and Alzheimer’s disease (AD). Recent evidence indicates they may
work via direct activation of TrkB, but most investigations have focused on traditional targets associated with
these agents, such as 5-HT1A/2A, and few studies have used AD models. We propose to study binding partners
of psychoplastogens and effects of kinase signaling and gene expression in human AD patients derived iPSCs
via multi-omic analysis.
Public Health Relevance Statement
Project Narrative
There is an ongoing substance abuse epidemic in western society. Synthetic psychoactive agents are among the
newest, most popular, and least understood of the abused substances. This work focuses on the development of
a new platform to understand bath salts and related agents to define novel therapeutic targets to treat toxicity and
episodic lethality.
No Sub Projects information available for 3U01DA054330-03S1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 3U01DA054330-03S1
Patents
No Patents information available for 3U01DA054330-03S1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 3U01DA054330-03S1
Clinical Studies
No Clinical Studies information available for 3U01DA054330-03S1
News and More
Related News Releases
No news release information available for 3U01DA054330-03S1
History
No Historical information available for 3U01DA054330-03S1
Similar Projects
No Similar Projects information available for 3U01DA054330-03S1